Literature DB >> 2642534

The development and initial validation of a sensitive bedside cognitive screening test.

D Faust1, B S Fogel.   

Abstract

Brief bedside cognitive examinations such as the Mini-Mental State Examination are designed to detect delirium and dementia but not more subtle or delineated cognitive deficits. Formal neuropsychological evaluation provides greater sensitivity and detects a wider range of cognitive deficits but is too lengthy for efficient use at the bedside or in epidemiological studies. The authors developed the High Sensitivity Cognitive Screen (HSCS), a 20-minute interview-based test, to identify patients who show disorder on formal neuropsychological evaluation. An initial study demonstrated satisfactory test-retest and interrater reliability. The HSCS was then administered to 60 psychiatric and neurological patients with suspected cognitive deficits but without gross impairment, who also completed formal neuropsychological testing. Results of both tests were independently classified as either normal, borderline, or abnormal. The HSCS correctly classified 93% of patients across the normal-abnormal dichotomy and showed promise for characterizing the extent and severity of cognitive dysfunction.

Entities:  

Mesh:

Year:  1989        PMID: 2642534     DOI: 10.1097/00005053-198901000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

Review 1.  An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Authors:  Yin Ting Cheung; Earl Hsien-Jie Tan; Alexandre Chan
Journal:  Support Care Cancer       Date:  2012-04-05       Impact factor: 3.603

Review 2.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

3.  Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.

Authors:  Jennifer R Klemp; Jamie S Myers; Carol J Fabian; Bruce F Kimler; Qamar J Khan; Susan M Sereika; Annette L Stanton
Journal:  Support Care Cancer       Date:  2017-08-28       Impact factor: 3.603

4.  The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.

Authors:  Debra L Barton; Kelli Burger; Paul J Novotny; Tom R Fitch; Sadhna Kohli; Gamini Soori; Mary Beth Wilwerding; Jeff A Sloan; Lisa A Kottschade; Kendrith M Rowland; Shaker R Dakhil; Daniel A Nikcevich; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2012-11-13       Impact factor: 3.603

5.  Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study.

Authors:  Federica Andreis; Marco Ferri; Maria Mazzocchi; Fausto Meriggi; Anna Rizzi; Luigina Rota; Brunella Di Biasi; Chiara Abeni; Claudio Codignola; Renzo Rozzini; Alberto Zaniboni
Journal:  Support Care Cancer       Date:  2012-08-11       Impact factor: 3.603

6.  Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.

Authors:  Q Wang; Z Jiang; X Qi; S Lu; S Wang; C Leng; F Lu; H Liu; S Liang; J Shi
Journal:  Clin Transl Oncol       Date:  2014-06-04       Impact factor: 3.405

7.  A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment.

Authors:  M Brazzelli; E Capitani; S Della Sala; H Spinnler; M Zuffi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

8.  Assessing cognitive function in cancer patients.

Authors:  Janette Vardy; Karen Wong; Qi-Long Yi; Alison Park; Paul Maruff; Lynne Wagner; Ian F Tannock
Journal:  Support Care Cancer       Date:  2006-03-15       Impact factor: 3.359

9.  Cancer-related cognitive impairment in breast cancer survivors: An examination of conceptual and statistical cognitive domains using principal component analysis.

Authors:  Maude Lambert; Lea Ann Ouimet; Cynthia Wan; Angela Stewart; Barbara Collins; Irene Vitoroulis; Catherine Bielajew
Journal:  Oncol Rev       Date:  2018-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.